, Volume 15, Issue 2, pp 277–282 | Cite as

Delayed diagnosis of disorder of sex development (DSD) due to P450 oxidoreductase (POR) deficiency

  • Vasiliki Koika
  • Anastasia K. Armeni
  • Neoklis A. GeorgopoulosEmail author
Case report


CASE PRESENTATION: A 36-year old man, operated on for cryptorchidism at the age of 8 years, was referred to the Outpatient Clinic of Reproductive Endocrinology for investigation of infertility. Clinical examination revealed ambiguous genitalia: penis 4–5 cm, testicular volume 2–3 ml, hypospadias, hypertrophic foreskin and scrotum bifida. Mild hypertension was confirmed. No skeletal malformations were detected. DESIGN: Hormonal and electrolytic determinations as well as semen analysis were conducted. PCR of the coding regions of 17-hydroxylase/17,20 lyase (P450c17) and of P450 oxidoreductase (POR) genes was also performed. RESULTS: Normal levels of electrolytes, low levels of androgens, high levels of gonadotropins and 17-hydroxyprogesterone as well as azoospermia were detected. Karyotype was shown to be 46,XY. Both hCG and ACTH stimulation significantly increased 17-hydroxyprogesterone with no increase in androgens. The diagnosis was congenital adrenal hyperplasia with apparent combined P450c17 and P450c21 deficiency due to mutations in the POR gene. Sequencing of the POR gene revealed: one deletion in exon 12 (Del 1696_1698delGTC >del531Valine) and one missense mutation in exon 7 (A259G) as well as two polymorphisms: rs1057868 (C/T A503V) and rs1057870 (G/A S572S) in exons 12 and 13, respectively. No nucleotide changes were detected in the 8 exons of P450c17. CONCLUSIONS: Molecular findings were consistent with the diagnosis of P450 oxidoreductase deficiency. Despite this severe deficiency, skeletal malformations simulating Antley-Bixler syndrome, which usually characterize the most severe forms, were not confirmed. This discrepancy could be attributed to the differential impact of a POR variant on each one of the P450 enzymes.

Key words

POR deficiency Mutation Male pseudohermaphroditism Disorder of sex development DSD Ambiguous genitalia P450 oxidoreductase 


  1. 1.
    Fluck CE, Tajima T, Pandey AV, et al, 2004 Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome. Nat Genet 36: 228–230.CrossRefGoogle Scholar
  2. 2.
    Miller WL, Huang N, Fluck CE, Pandey AV, 2004 P450 oxidoreductase deficiency. Lancet 364: 1663.CrossRefGoogle Scholar
  3. 3.
    Pandey AV, Fluck CE, 2013 NADPH P450 oxidoreductase: structure, function, and pathology of diseases. Pharmacol Ther 138: 229–254.CrossRefGoogle Scholar
  4. 4.
    Pandey AV, Sproll P, 2014 Pharmacogenomics of human P450 oxidoreductase. Front Pharmacol 5: 103.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Peterson RE, Imperato-McGinley J, Gautier T, Shackleton C, 1985 Male pseudohermaphroditism due to multiple defects in steroid-biosynthetic microsomal mixed-function oxidases. A new variant of congenital adrenal hyperplasia. N Engl J Med 313: 1182–1191.CrossRefGoogle Scholar
  6. 6.
    Shen AL, O’Leary KA, Kasper CB, 2002 Association of multiple developmental defects and embryonic lethality with loss of microsomal NADPH-cytochrome P450 oxidoreductase. J Biol Chem 277: 6536–6541.CrossRefGoogle Scholar
  7. 7.
    Otto DM, Henderson CJ, Carrie D, et al, 2003 Identification of novel roles of the cytochrome p450 system in early embryogenesis: effects on vasculogenesis and retinoic Acid homeostasis. Mol Cell Biol 23: 6103–6116.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Huang N, Pandey AV, Agrawal V, et al, 2005 Diversity and function of mutations in p450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidogenesis. Am J Hum Genet 76: 729–749.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Dhir V, Ivison HE, Krone N, et al, 2007 Differential inhibition of CYP17A1 and CYP21A2 activities by the P450 oxidoreductase mutant A287P. Mol Endocrinol 21: 1958–1968.CrossRefGoogle Scholar
  10. 10.
    Pandey AV, Kempna P, Hofer G, Mullis PE, Fluck CE, 2007 Modulation of human CYP19A1 activity by mutant NADPH P450 oxidoreductase. Mol Endocrinol 21: 2579–2595.CrossRefGoogle Scholar
  11. 11.
    Fluck CE, Mallet D, Hofer G, et al, 2011 Deletion of P399_E401 in NADPH cytochrome P450 oxidoreductase results in partial mixed oxidase deficiency. Biochem Biophys Res Commun 412: 572–577.CrossRefGoogle Scholar
  12. 12.
    Fukami M, Nishimura G, Homma K, et al, 2009 Cytochrome P450 oxidoreductase deficiency: identification and characterization of biallelic mutations and genotype-phenotype correlations in 35 Japanese patients. J Clin Endocrinol Metab 94: 1723–1731.CrossRefGoogle Scholar
  13. 13.
    Scott RR, Miller WL, 2008 Genetic and clinical features of p450 oxidoreductase deficiency. Horm Res 69: 266–275.CrossRefGoogle Scholar
  14. 14.
    Sahakitrungruang T, Huang N, Tee MK, et al, 2009 Clinical, genetic, and enzymatic characterization of P450 oxidoreductase deficiency in four patients. J Clin Endocrinol Metab 94: 4992–5000.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Miller WL, Agrawal V, Sandee D, et al, 2011 Consequences of POR mutations and polymorphisms. Mol Cell Endocrinol 336: 174–179.CrossRefGoogle Scholar
  16. 16.
    Krone NI, Reisch N, Idkowiak J, et al, 2012 Genotype-phenotype analysis in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency. J Clin Endocrinol Metab 97: E257–267.CrossRefGoogle Scholar
  17. 17.
    Yang J, Cui B, Sun S, et al, 2006 Phenotype-genotype correlation in eight Chinese 17alpha-hydroxylase/17,20 lyase-deficiency patients with five novel mutations of CYP17A1 gene. J Clin Endocrinol Metab 91: 3619–3625.CrossRefGoogle Scholar
  18. 18.
    Arlt W, Walker EA, Draper N, et al, 2004 Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: analytical study. Lancet 363: 2128–2135.CrossRefGoogle Scholar
  19. 19.
    Schwarz JM, Cooper DN, Schuelke M, Seelow D, 2014 MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods 11: 361–362.CrossRefGoogle Scholar
  20. 20.
    Ng PC, Henikoff S, 2003 SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res 31: 3812–3814.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Acharya V, Nagarajaram HA, 2012 Hansa: an automated method for discriminating disease and neutral human nsSNPs. Hum Mutat 33: 332–337.CrossRefGoogle Scholar
  22. 22.
    Acharya V, Nagarajaram HA, 2013 Response to: Statistical analysis of missense mutation classifiers. Hum Mutat 34: 407.CrossRefGoogle Scholar
  23. 23.
    Fukami M, Horikawa R, Nagai T, et al, 2005 Cytochrome P450 oxidoreductase gene mutations and Antley-Bixler syndrome with abnormal genitalia and/or impaired steroidogenesis: molecular and clinical studies in 10 patients. J Clin Endocrinol Metab 90: 414–426.CrossRefGoogle Scholar
  24. 24.
    Pandey AV, 2006 Biochemical analysis of mutations in P450 oxidoreductase. Biochem Soc Trans 34: 1186–1191.CrossRefGoogle Scholar
  25. 25.
    Miller WL, 2004 P450 oxidoreductase deficiency: a new disorder of steroidogenesis with multiple clinical manifestations. Trends Endocrinol Metab 15: 311–315.CrossRefGoogle Scholar
  26. 26.
    Miller WL, Huang N, Pandey AV, Fluck CE, Agrawal V, 2005 P450 oxidoreductase deficiency: a new disorder of steroidogenesis. Ann N Y Acad Sci 1061: 100–108.CrossRefGoogle Scholar
  27. 27.
    Hershkovitz E, Parvari R, Wudy SA, et al, 2008 Homozygous mutation G539R in the gene for P450 oxidoreductase in a family previously diagnosed as having 17,20-lyase deficiency. J Clin Endocrinol Metab 93: 3584–3588.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Huang N, Agrawal V, Giacomini KM, Miller WL, 2008 Genetics of P450 oxidoreductase: sequence variation in 842 individuals of four ethnicities and activities of 15 missense mutations. Proc Natl Acad Sci U S A 105: 1733–1738.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Gomes LG, Huang N, Agrawal V, Mendonca BB, Bachega TA, Miller WL, 2008 The common P450 oxidoreductase variant A503V is not a modifier gene for 21-hydroxylase deficiency. J Clin Endocrinol Metab 93: 2913–2916.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Miller WL, Huang N, Agrawal V, Giacomini KM, 2009 Genetic variation in human P450 oxidoreductase. Mol Cell Endocrinol 300: 180–184.CrossRefGoogle Scholar

Copyright information

© Hellenic Endocrine Society 2016

Authors and Affiliations

  • Vasiliki Koika
    • 1
  • Anastasia K. Armeni
    • 1
  • Neoklis A. Georgopoulos
    • 1
    Email author
  1. 1.Department of Obstetrics and Gynecology, Division of Reproductive EndocrinologyUniversity of Patras Medical School, University HospitalPatrasGreece

Personalised recommendations